MorphoSys Further Strengthens US Patent Position on Core Technologies

07-Oct-2010 - Germany

MorphoSys AG announced that the US Patent and Trademark Office (USPTO) has granted a new patent providing extended protection for the company's CysDisplay technology. The new patent (US 7,785,859) covers the host cells used in this enhanced phage display technology. Currently, the company is prosecuting more than 35 different proprietary patent families worldwide, in addition to about the same number of patent families being pursued in cooperation with its partners.

"Today's news marks yet another step in extending our strong intellectual property portfolio in key pharmaceutical markets like the US," commented Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG. "We are committed to maximizing the patent protection on our core technologies, as these are essential value-drivers for the company."

Other news from the department research and development

More news from our other portals

All FT-IR spectrometer manufacturers at a glance